200 related articles for article (PubMed ID: 36078043)
1. Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular Bioenergetics.
D'Annibale OM; Phua YL; Van't Land C; Karunanidhi A; Dorenbaum A; Mohsen AW; Vockley J
Cells; 2022 Aug; 11(17):. PubMed ID: 36078043
[No Abstract] [Full Text] [Related]
2. Bezafibrate activation of PPAR drives disturbances in mitochondrial redox bioenergetics and decreases the viability of cells from patients with VLCAD deficiency.
Lund M; Andersen KG; Heaton R; Hargreaves IP; Gregersen N; Olsen RKJ
Biochim Biophys Acta Mol Basis Dis; 2021 Jun; 1867(6):166100. PubMed ID: 33549744
[TBL] [Abstract][Full Text] [Related]
3. Characterization of exonic variants of uncertain significance in very long-chain acyl-CoA dehydrogenase identified through newborn screening.
D'Annibale OM; Koppes EA; Sethuraman M; Bloom K; Mohsen AW; Vockley J
J Inherit Metab Dis; 2022 May; 45(3):529-540. PubMed ID: 35218577
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency.
Schiff M; Mohsen AW; Karunanidhi A; McCracken E; Yeasted R; Vockley J
Mol Genet Metab; 2013 May; 109(1):21-7. PubMed ID: 23480858
[TBL] [Abstract][Full Text] [Related]
5. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
[TBL] [Abstract][Full Text] [Related]
6. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
[TBL] [Abstract][Full Text] [Related]
7. One potential hotspot ACADVL mutation in Chinese patients with very-long-chain acyl-coenzyme A dehydrogenase deficiency.
Li X; Ma R; Liu Y; Kang L; He R; Song J; Ren J; Li Y; Huang M; Men J; Yang Y
Clin Chim Acta; 2020 Apr; 503():218-222. PubMed ID: 31794763
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
[TBL] [Abstract][Full Text] [Related]
9. Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.
Tenopoulou M; Chen J; Bastin J; Bennett MJ; Ischiropoulos H; Doulias PT
J Biol Chem; 2015 Apr; 290(16):10486-94. PubMed ID: 25737446
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers.
Seminotti B; Leipnitz G; Karunanidhi A; Kochersperger C; Roginskaya VY; Basu S; Wang Y; Wipf P; Van Houten B; Mohsen AW; Vockley J
Hum Mol Genet; 2019 Mar; 28(6):928-941. PubMed ID: 30445591
[TBL] [Abstract][Full Text] [Related]
11. AAV9 gene replacement therapy for respiratory insufficiency in very-long chain acyl-CoA dehydrogenase deficiency.
Zieger M; Keeler AM; Flotte TR; ElMallah MK
J Inherit Metab Dis; 2019 Sep; 42(5):870-877. PubMed ID: 30993714
[TBL] [Abstract][Full Text] [Related]
12. Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglyceride.
Gaston G; Gangoiti JA; Winn S; Chan B; Barshop BA; Harding CO; Gillingham MB
J Inherit Metab Dis; 2020 Nov; 43(6):1232-1242. PubMed ID: 33448436
[TBL] [Abstract][Full Text] [Related]
13. Synthetic mRNA rescues very long-chain acyl-CoA dehydrogenase deficiency in patient fibroblasts and a murine model.
Zhao XJ; Mohsen AW; Mihalik S; Solo K; Aliu E; Shi H; Basu S; Kochersperger C; Van't Land C; Karunanidhi A; Coughlan KA; Siddiqui S; Rice LM; Hillier S; Guadagnin E; Giangrande PH; Martini PGV; Vockley J
Mol Genet Metab; 2023 Jan; 138(1):106982. PubMed ID: 36580829
[TBL] [Abstract][Full Text] [Related]
14. Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy.
Keeler AM; Conlon T; Walter G; Zeng H; Shaffer SA; Dungtao F; Erger K; Cossette T; Tang Q; Mueller C; Flotte TR
Mol Ther; 2012 Jun; 20(6):1131-8. PubMed ID: 22395529
[TBL] [Abstract][Full Text] [Related]
15. Impairment of mitochondrial bioenergetics and permeability transition induction caused by major long-chain fatty acids accumulating in VLCAD deficiency in skeletal muscle as potential pathomechanisms of myopathy.
Cecatto C; Amaral AU; Roginski AC; Castilho RF; Wajner M
Toxicol In Vitro; 2020 Feb; 62():104665. PubMed ID: 31629068
[TBL] [Abstract][Full Text] [Related]
16. Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.
Xiong D; He H; James J; Tokunaga C; Powers C; Huang Y; Osinska H; Towbin JA; Purevjav E; Balschi JA; Javadov S; McGowan FX; Strauss AW; Khuchua Z
Am J Physiol Heart Circ Physiol; 2014 Feb; 306(3):H326-38. PubMed ID: 24285112
[TBL] [Abstract][Full Text] [Related]
17. Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States.
Miller MJ; Burrage LC; Gibson JB; Strenk ME; Lose EJ; Bick DP; Elsea SH; Sutton VR; Sun Q; Graham BH; Craigen WJ; Zhang VW; Wong LJ
Mol Genet Metab; 2015 Nov; 116(3):139-45. PubMed ID: 26385305
[TBL] [Abstract][Full Text] [Related]
18. Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.
Tucci S; Flögel U; Hermann S; Sturm M; Schäfers M; Spiekerkoetter U
Biochim Biophys Acta; 2014 May; 1842(5):677-85. PubMed ID: 24530811
[TBL] [Abstract][Full Text] [Related]
19. Adult-onset very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD).
Fatehi F; Okhovat AA; Nilipour Y; Mroczek M; Straub V; Töpf A; Palibrk A; Peric S; Rakocevic Stojanovic V; Najmabadi H; Nafissi S
Eur J Neurol; 2020 Nov; 27(11):2257-2266. PubMed ID: 32558070
[TBL] [Abstract][Full Text] [Related]
20. Novel ACADVL variants resulting in mitochondrial defects in long-chain acyl-CoA dehydrogenase deficiency.
Chen T; Tong F; Wu XY; Zhu L; Yi QZ; Zheng J; Yang RL; Zhao ZY; Cang XH; Shu Q; Jiang PP
J Zhejiang Univ Sci B; 2020 Nov.; 21(11):885-896. PubMed ID: 33150772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
